Drug Profile
A 177775
Latest Information Update: 24 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antihormones
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female infertility
Most Recent Events
- 24 Jan 2013 Discontinued - Preclinical for Female infertility in USA (unspecified route)
- 30 Jun 2000 Preclinical development for Female infertility in USA (Unknown route)